Illumina, Inc.
Nasdaq ILMN · San Diego, CA
Works in Genetic & rare · Renal & urogenital · Women's health
Illumina, Inc. is a clinical trial sponsor based in San Diego, CA, listed as Nasdaq ILMN. It has no active clinical trials as lead sponsor; its trials since 2021 were in Genetic & rare, Renal & urogenital and Women's health. Since 2021 it has completed 5 trials and stopped 0 early. Its FDA record on file shows 1 recall.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq ILMN
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Illumina, Inc
No warning letter naming Illumina, Inc is on file. FDA has published 1 recall naming it.
Yes. FDA's enforcement reports list 1 recall by Illumina, Inc; the latest, reported on 2026-10-07, is a Class II recall.
Illumina, Inc has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 5 trials and stopped 0 early.
Illumina, Inc is based in San Diego, CA and is listed as Nasdaq ILMN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Illumina, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-05-01.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Illumina, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.